疏水交互作用層析法市場－全球產業規模、佔有率、趨勢、機會和預測：按產品和服務、樣品類型、最終用戶、地區和競爭格局分類，2021-2031年

全球疏水交互作用層析法市場預計將從 2025 年的 4.2048 億美元成長到 2031 年的 6.3921 億美元，複合年成長率為 7.23%。

疏水交互作用層析法(HIC) 是一種利用表面疏水性差異，在高鹽環境下透過與疏水配體的可逆相互作用來純化生物分子的特殊分離技術。市場成長主要受全球單株抗體和重組疫苗產量不斷成長的驅動，這些產品需要非變性純化步驟來有效去除聚集體和變異體。儘管自動化程度不斷提高，但由於該技術能夠在保持生物活性的同時實現高純度，因此仍然是下游生物加工的重要組成部分。

然而，由於方法開發的複雜性，市場面臨著許多障礙，因為最佳化鹽的類型和濃度以平衡結合能力和產率需要先進的技術專長。雖然這項操作挑戰可能會延緩製程驗證，但生物製藥管線的巨額投資為該產業提供了支持。例如，歐洲製藥工業協會聯合會（EFPIA）報告稱，到2024年，以研發為基礎的製藥業將在歐洲的研發領域投資約550億歐元，這凸顯了推動複雜療法研發的強大資金投入，而這些療法需要此類先進的純化技術。

市場促進因素

全球生物製藥產業的快速成長正成為疏水交互作用層析法（ HIC）市場擴張的主要催化劑。隨著製造商擴大生產規模以應對慢性病患者數量的成長，對能夠處理更高通量的下游加工技術的需求也隨之增加。生產基礎設施的大規模資本投資印證了這個趨勢。例如，諾和諾德在2024年6月宣布，將投資41億美元在北卡羅來納州克萊頓新建一座工廠，以擴大其注射劑的供應。如此大規模的產能投資將直接擴大純化管柱和樹脂的安裝基礎，因為HIC對於確保這些大分子藥物的穩定性和有效性至關重要。

同時，單株抗體和重組蛋白的激增需求也推動了這種分離技術的應用。疏水相互作用層析（HIC）因其能夠在不損害分子結構完整性的前提下去除聚集體和宿主細胞蛋白，在抗體工作流程中備受青睞。這種強勁的研發動能也體現在監管層面。美國食品藥物管理局（FDA）於2024年12月發布了《2024年新藥核准報告》，其中列出了50種新分子實體（NME）的核准，凸顯了複雜生物製藥的持續湧入。為了支持這些藥物的商業化，契約製造生產商正在擴展其純化能力，例如三星生物製劑公司於2024年10月獲得了一份價值約12.4億美元的創紀錄的生產合約。這進一步強調了該行業對高純度治療性蛋白質的先進生物製程解決方案的依賴。

市場挑戰

全球疏水交互作用層析法(HIC) 市場成長面臨的主要挑戰之一是方法開發本身的複雜性，這需要先進的技術專長才能有效實施。 HIC 需要精確最佳化關鍵參數，例如鹽的類型和濃度，並且結合能力和蛋白質穩定性之間的微妙平衡至關重要。與更簡單的純化技術不同，HIC 常常表現出反直覺的行為，操作條件的微小偏差都可能導致產量顯著下降或蛋白質變性。這種對先進技術的高度依賴造成了下游加工的瓶頸。企業難以招募和留住執行此複雜開發週期所需的高技能人才，導致製程驗證和產品商業化進程的延誤。

生物製藥生產領域日益嚴重的人才短缺進一步加劇了這項營運瓶頸。缺乏能夠管理先進純化平台的合格科學家和技術人員，限制了該行業擴大規模以滿足不斷成長的需求。根據國家生物製程研究與培訓研究所 (NIBRT) 預測，到 2027 年，生物製藥產業預計將需要超過 21,000 名新人才，而目前每年卻面臨約 3,000 名技術畢業生的嚴重缺口。這種技術人才短缺直接阻礙了疏水交互作用層析法等複雜技術的廣泛高效應用，儘管生物製藥研發管線實力雄厚，但仍阻礙了市場擴張。

市場趨勢

在抗體藥物複合體(ADC) 純化中採用疏水交互作用層析法，從根本上重塑了市場對技術的需求。與標準抗體不同，ADC 由於偶聯了細胞毒性有效載荷，具有顯著的疏水異質性，因此這種分離模式對於基於藥物抗體比 (DAR) 進行有效分類至關重要。該技術使生產商能夠在去除未結合抗體的同時，分離出標靶治療藥物。這種向複雜偶聯藥物的結構性轉變得到了大規模生產投資的支持。例如，Astra Zeneca於 2024 年 5 月宣布投資 15 億美元，在新加坡建立專門用於此類標靶治療的生產設施，從而確保了對能夠處理偶聯分子的分離介質的持續需求。

此外，基因治療和病毒載體純化領域應用的不斷拓展，正催生出與傳統蛋白質工作流程截然不同的成長軌跡。腺結合病毒(AAV) 的生產正日益利用細微的疏水性差異，將含有遺傳有效載荷的完整衣殼與空衣殼分離，這對於最大限度地提高治療效果和降低病毒總載量至關重要。不斷成長的先進治療方法臨床研發管線也推動了這一領域的發展。根據美國基因與細胞治療學會 (ASGCT) 2024 年 4 月發布的報告，基因、細胞和 RNA 療法的研發管線已達 4,096 種藥物，這表明針對病毒載體最佳化的純化方法的應用範圍正在不斷擴大。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

5. 全球疏水交互作用層析法市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品/服務分類（樹脂、層析管、HIC層析管、緩衝溶液、服務等）
  • 依樣本類型（單株抗體、疫苗、其他樣本）
  • 按最終用戶（製藥/生物製藥公司、CRO/CMO、研究/學術機構、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美疏水交互作用層析法市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲疏水交互作用層析法市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區疏水交互作用層析法市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲疏水交互作用層析法市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

10. 南美洲疏水交互作用層析法市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球疏水交互作用層析法市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Bio-Rad Laboratories, Inc.
• Sartorius AG
• Thermo Fisher Scientific Inc.
• Tosoh Bioscience
• Geno Technology Inc.
• Axel Semrau GmbH
• PerkinElmer Inc.
• Cecil Instrumentation Services Ltd
• Hitachi High-Tech Corporation
• Agilent Technologies, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Hydrophobic Interaction Chromatography Market is projected to expand from USD 420.48 Million in 2025 to USD 639.21 Million by 2031, growing at a CAGR of 7.23%. Hydrophobic Interaction Chromatography (HIC) is a specialized separation method that purifies biomolecules by leveraging differences in surface hydrophobicity through reversible interactions with hydrophobic ligands in high-salt environments. Market growth is largely driven by the rising global production of monoclonal antibodies and recombinant vaccines, which require non-denaturing polishing steps to remove aggregates and variants effectively. Because this technology maintains biological activity while achieving high purity, it remains a fundamental component of downstream bioprocessing, regardless of broader automation trends.

However, the market encounters a significant obstacle due to the complexity of method development, as optimizing salt type and concentration to balance binding capacity and yield requires considerable technical expertise. Although this operational challenge can delay process validation, the sector is supported by substantial investment in biologic drug pipelines. For instance, the European Federation of Pharmaceutical Industries and Associations reported that in 2024, the research-based pharmaceutical industry invested approximately €55,000 million in R&D across Europe, underscoring the strong financial commitment propelling the development of complex therapeutics that demand such sophisticated purification technologies.

Market Driver

The rapid growth of the global biopharmaceutical industry serves as a primary catalyst for the expansion of the hydrophobic interaction chromatography market. As manufacturers scale operations to address the increasing prevalence of chronic diseases, there is a concurrent need for downstream processing technologies capable of managing higher throughput. This trend is illustrated by major capital investments in production infrastructure; for example, Novo Nordisk announced in June 2024 a $4.1 billion commitment to build a new facility in Clayton, North Carolina, specifically to boost the supply of injectable treatments. Such significant capacity investments directly increase the installation base for purification columns and resins, as HIC remains critical for ensuring the stability and potency of these large-molecule therapeutics.

Simultaneously, the surging demand for monoclonal antibodies and recombinant proteins drives the adoption of this separation technique. HIC is particularly esteemed in antibody workflows for its ability to clear aggregates and host cell proteins without compromising the molecule's structural integrity. This intense development activity is reflected in the regulatory landscape; the U.S. Food and Drug Administration's 'Novel Drug Approvals for 2024' report from December 2024 noted the approval of 50 new molecular entities, highlighting a continuous influx of complex biologics. To support this commercialization, contract manufacturing organizations are expanding their purification capabilities, as seen in October 2024 when Samsung Biologics secured a record manufacturing contract worth approximately $1.24 billion, further validating the industry's reliance on advanced bioprocessing solutions for high-purity therapeutic proteins.

Market Challenge

The primary challenge restricting the growth of the Global Hydrophobic Interaction Chromatography Market is the inherent complexity associated with method development, which requires substantial technical expertise to execute effectively. HIC demands precise optimization of critical parameters, such as salt type and concentration, to manage the delicate balance between binding capacity and protein stability. Unlike simpler purification techniques, HIC often exhibits non-intuitive behaviors where slight deviations in operating conditions can result in significant yield losses or protein denaturation. This high dependency on specialized knowledge creates a bottleneck in downstream processing, as companies struggle to recruit and retain personnel with the advanced skills needed to navigate these intricate development cycles, thereby delaying process validation and product commercialization.

This operational constraint is severely exacerbated by a widening workforce gap within the biopharmaceutical manufacturing sector. The shortage of qualified scientists and engineers capable of managing sophisticated purification platforms limits the industry's ability to scale operations to meet rising demand. According to the National Institute for Bioprocessing Research and Training (NIBRT), the biopharma sector was projected in 2024 to require over 21,000 new jobs by 2027, yet it faces a critical forecasted shortfall of approximately 3,000 skilled graduates annually. This deficit in available technical talent directly impedes the broader adoption and efficient implementation of complex technologies like hydrophobic interaction chromatography, stifling market expansion despite the robust pipeline of biologic drugs.

Market Trends

The adoption of hydrophobic interaction chromatography for antibody-drug conjugate (ADC) purification is fundamentally reshaping technical requirements within the market. Unlike standard antibodies, ADCs possess significant hydrophobic heterogeneity due to the conjugation of cytotoxic payloads, necessitating this separation mode to effectively resolve species based on the drug-antibody ratio (DAR). This capability allows manufacturers to isolate the target therapeutic profile while removing unconjugated antibodies. This structural shift toward complex conjugated modalities is evidenced by substantial manufacturing commitments; for instance, AstraZeneca announced in May 2024 a $1.5 billion capital outlay to establish a facility in Singapore dedicated to these targeted treatments, ensuring sustained demand for separation media capable of handling conjugated molecules.

Furthermore, the expansion of applications in gene therapy and viral vector purification creates a distinct growth trajectory separate from traditional protein workflows. In adeno-associated virus (AAV) manufacturing, this technique is increasingly utilized to separate full capsids containing the genetic payload from empty capsids by exploiting subtle hydrophobic differences, which is vital for maximizing therapeutic potency and reducing total viral load. The segment's expansion is supported by a widening clinical pipeline for advanced therapies; according to the American Society of Gene & Cell Therapy's April 2024 report, the pipeline for gene, cell, and RNA therapies reached 4,096 candidates, indicating a broadening application base for purification methods optimized for viral vectors.

Key Market Players

• Bio-Rad Laboratories, Inc.
• Sartorius AG
• Thermo Fisher Scientific Inc.
• Tosoh Bioscience
• Geno Technology Inc.
• Axel Semrau GmbH
• PerkinElmer Inc.
• Cecil Instrumentation Services Ltd
• Hitachi High-Tech Corporation
• Agilent Technologies, Inc.

Report Scope

In this report, the Global Hydrophobic Interaction Chromatography Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hydrophobic Interaction Chromatography Market, By Product and Services

• Resins
• Columns
• HIC Columns
• Buffers
• Services
• Others

Hydrophobic Interaction Chromatography Market, By Sample Type

• Monoclonal Antibodies
• Vaccines
• Other Samples

Hydrophobic Interaction Chromatography Market, By End User

• Pharmaceutical and Biopharmaceutical Companies
• Contract Research Organizations and Contract Manufacturing Organizations
• Research and Academic Institutes
• others

Hydrophobic Interaction Chromatography Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hydrophobic Interaction Chromatography Market.

Available Customizations:

Global Hydrophobic Interaction Chromatography Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hydrophobic Interaction Chromatography Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product and Services (Resins, Columns, HIC Columns, Buffers, Services, Others)
  • 5.2.2. By Sample Type (Monoclonal Antibodies, Vaccines, Other Samples)
  • 5.2.3. By End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations and Contract Manufacturing Organizations, Research and Academic Institutes, others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Hydrophobic Interaction Chromatography Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product and Services
  • 6.2.2. By Sample Type
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Hydrophobic Interaction Chromatography Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product and Services
      • 6.3.1.2.2. By Sample Type
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Hydrophobic Interaction Chromatography Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product and Services
      • 6.3.2.2.2. By Sample Type
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Hydrophobic Interaction Chromatography Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product and Services
      • 6.3.3.2.2. By Sample Type
      • 6.3.3.2.3. By End User

7. Europe Hydrophobic Interaction Chromatography Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product and Services
  • 7.2.2. By Sample Type
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Hydrophobic Interaction Chromatography Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product and Services
      • 7.3.1.2.2. By Sample Type
      • 7.3.1.2.3. By End User
  • 7.3.2. France Hydrophobic Interaction Chromatography Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product and Services
      • 7.3.2.2.2. By Sample Type
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Hydrophobic Interaction Chromatography Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product and Services
      • 7.3.3.2.2. By Sample Type
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Hydrophobic Interaction Chromatography Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product and Services
      • 7.3.4.2.2. By Sample Type
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Hydrophobic Interaction Chromatography Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product and Services
      • 7.3.5.2.2. By Sample Type
      • 7.3.5.2.3. By End User

8. Asia Pacific Hydrophobic Interaction Chromatography Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product and Services
  • 8.2.2. By Sample Type
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Hydrophobic Interaction Chromatography Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product and Services
      • 8.3.1.2.2. By Sample Type
      • 8.3.1.2.3. By End User
  • 8.3.2. India Hydrophobic Interaction Chromatography Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product and Services
      • 8.3.2.2.2. By Sample Type
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Hydrophobic Interaction Chromatography Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product and Services
      • 8.3.3.2.2. By Sample Type
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Hydrophobic Interaction Chromatography Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product and Services
      • 8.3.4.2.2. By Sample Type
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Hydrophobic Interaction Chromatography Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product and Services
      • 8.3.5.2.2. By Sample Type
      • 8.3.5.2.3. By End User

9. Middle East & Africa Hydrophobic Interaction Chromatography Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product and Services
  • 9.2.2. By Sample Type
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Hydrophobic Interaction Chromatography Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product and Services
      • 9.3.1.2.2. By Sample Type
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Hydrophobic Interaction Chromatography Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product and Services
      • 9.3.2.2.2. By Sample Type
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Hydrophobic Interaction Chromatography Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product and Services
      • 9.3.3.2.2. By Sample Type
      • 9.3.3.2.3. By End User

10. South America Hydrophobic Interaction Chromatography Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product and Services
  • 10.2.2. By Sample Type
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Hydrophobic Interaction Chromatography Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product and Services
      • 10.3.1.2.2. By Sample Type
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Hydrophobic Interaction Chromatography Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product and Services
      • 10.3.2.2.2. By Sample Type
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Hydrophobic Interaction Chromatography Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product and Services
      • 10.3.3.2.2. By Sample Type
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Hydrophobic Interaction Chromatography Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Bio-Rad Laboratories, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Sartorius AG
• 15.3. Thermo Fisher Scientific Inc.
• 15.4. Tosoh Bioscience
• 15.5. Geno Technology Inc.
• 15.6. Axel Semrau GmbH
• 15.7. PerkinElmer Inc.
• 15.8. Cecil Instrumentation Services Ltd
• 15.9. Hitachi High-Tech Corporation
• 15.10. Agilent Technologies, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer